Dr. Christopher McGowan, MD, an obesity medicine specialist at True You Weight Loss, says the decision to drink on Ozempic is ...

A surge of alternatives to newly popular weight-loss drugs is facing its biggest test yet after the FDA warned companies ...

Tirzepatide, a dual GIP and GLP-1 receptor agonist, has gained widespread recognition for its effectiveness in promoting substantial weight loss by enhancing metabolic functions and controlling ...

Anticipating a 35% CAGR in 2025, Hims & Hers is poised for substantial growth. Read why I maintain my strong buy rating on ...

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and ...

GLP-1 supplement makers claim that their products work similarly to weight loss injections like Ozempic. Here's what experts ...

Research shows patients taking weight-loss drugs like Ozempic and Wegovy are more likely to have food left in the stomach or ...

MangoRx aims to capitalize on growing demand for GLP-1 treatments to drive revenue growth and expand market share in the weight loss ...

In it, he revealed that he had undergone significant weight loss. In the 25-minute video, the content creator asserted that he was "two steps ahead," adding that he had carried out the "greatest ...

With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its ...

What’s better for kidneys: bariatric surgery or diabetes medication? Find out how weight-loss surgery stacks up against GLP-1 ...

It’s similar with multiple sclerosis. Actually, there are so many good drugs out there. A lot of the market has already been ...